About Us
Stroke
Our product
Partners & Investors
News & Media
Contact

About Us

Nothing to display, yet.

About Us

Company Overview
Management Team
Project Team
Board of directors

May 19, 2017

Acticor reached the milestones triggering the second payment in the Research Agreement with its pharma partner Mediolanum

Acticor reached the milestones triggering the second payment in the Research Agreement with its pharma partner Mediolanum Phase 1 to start in October 2017 Paris, May 18th, 2017 – Acticor Biotech, a biotechnology company focused on the treatment of acute ischemic stroke, announced today that it has received its second payment from Mediolanum, triggered by […]

Main navigation

About Us
Stroke
Our product
Press Releases
Media Coverage
Publications
Investors

Contact

Contact Us
Follow us on Twitter
Follow us on LinkedIn

Acticor Biotech
Bâtiment Inserm U1148
Hôpital Bichat, Secteur Claude Bernard
46 rue Henri Huchard
75877 Paris Cedex 18